Clinical Trial Update: Premedication with Intranasal Dexmedetomidine in Sedation of Patients Undergoing Total Knee Arthroplasty [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating intranasal dexmedetomidine as premedication for sedation in patients undergoing total knee arthroplasty has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Knee Osteoarthritis
• Postoperative Pain

Drugs mentioned

• Dexmedetomidine (intranasal) (dexmedetomidine)

Snippet

Sponsor: Turku University Hospital | Conditions: Knee Osteoarthritis, Pain, Postoperative | Phase 4 | Status: COMPLETED